Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

This study has been completed.
Information provided by:
Sangamo Therapeutics Identifier:
First received: November 11, 2005
Last updated: September 2, 2016
Last verified: September 2016